melanocortin based peptide pt141. PT-141 PT-141 (Bremelanotide) UK: Research Peptide

Specimens were taken from 3 areas by punch biopsy to clarify the diagnosis

Beyond its approved indication, PT-141 has been investigated and used off-label for male erectile dysfunction, particularly in men who don't respond to PDE5 inhibitors or have contraindications to their use

Regulatory agencies classify these compounds as unapproved substances because they lack sufficient clinical development and verified safety data

(and potentially elsewhere) may recruit men with erectile dysfunction who have not responded to other treatments

Due to its broad receptor activity, Melanotan II is widely utilised in experimental studies examining melanogenesis, appetite signalling, metabolic regulation, and central nervous system pathways